4XI3
Estrogen Receptor Alpha Ligand Binding Domain in Complex with Bazedoxifene
Summary for 4XI3
Entry DOI | 10.2210/pdb4xi3/pdb |
Descriptor | Estrogen receptor, Bazedoxifene (3 entities in total) |
Functional Keywords | estrogen receptor, serm, bazedoxifene, breast cancer, nuclear hormone receptor, signaling protein |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 4 |
Total formula weight | 112960.98 |
Authors | Fanning, S.W.,Mayne, C.G.,Toy, W.,Carlson, K.,Greene, B.,Nowak, J.,Walter, R.,Panchamukhi, S.,Tajhorshid, E.,Nettles, K.W.,Chandarlapaty, S.,Katzenellenbogen, J.,Greene, G.L. (deposition date: 2015-01-06, release date: 2016-01-13, Last modification date: 2024-03-06) |
Primary citation | Fanning, S.W.,Jeselsohn, R.,Dharmarajan, V.,Mayne, C.G.,Karimi, M.,Buchwalter, G.,Houtman, R.,Toy, W.,Fowler, C.E.,Han, R.,Laine, M.,Carlson, K.E.,Martin, T.A.,Nowak, J.,Nwachukwu, J.C.,Hosfield, D.J.,Chandarlapaty, S.,Tajkhorshid, E.,Nettles, K.W.,Griffin, P.R.,Shen, Y.,Katzenellenbogen, J.A.,Brown, M.,Greene, G.L. The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells. Elife, 7:-, 2018 Cited by PubMed: 30489256DOI: 10.7554/eLife.37161 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.491 Å) |
Structure validation
Download full validation report